Results 61 to 70 of about 349 (107)

Management of Obese Patients with Cardiovascular Disease with Emerging Weight-Lowering Drugs: A Narrative Review. [PDF]

Biomedicines
Ciarloni A, Salvio G, Bordoni M, Giacchetti G, Balercia G.   +4 more
europepmc   +1 more source

New Drugs on the Block: Dietary Management and Nutritional Considerations During the Use of Anti-Obesity Medication. [PDF]

Nutrients
Pardali EC, Gkouskou KK, Cholevas C, Poulimeneas D, Tsiroukidou K, Goulis DG, Grammatikopoulou MG.   +6 more
europepmc   +1 more source

Should Incretin Agonist-Based Brugs be Considered for First Line Antihypertensive Therapy? [PDF]

Curr Hypertens Rep
Kylies D, Dreher L, Wenzel UO.
europepmc   +1 more source

Amylin: From Mode of Action to Future Clinical Potential in Diabetes and Obesity. [PDF]

Diabetes Ther
Volčanšek Š, Koceva A, Jensterle M, Janež A, Muzurović E.   +4 more
europepmc   +1 more source

Pharmacologic Disruption: How Emerging Weight Loss Therapies Are Challenging Bariatric Surgery Guidelines. [PDF]

Medicina (Kaunas)
Alqatari SG, Alwaheed AJ, Hasan MA, Al Argan RJ, Alabdullah MM, Al Shubbar MD.   +5 more
europepmc   +1 more source

Obesity pharmacotherapy reimagined: The era of multi-receptor agonists and next-generation metabolic modulators, perspectives and controversies. [PDF]

Metabol Open
Lempesis IG, Dalamaga M.
europepmc   +1 more source

Nutrient-Stimulated Hormone-Based Therapies: Transforming Obesity Management. [PDF]

Endocrinol Metab (Seoul)
Kwak KH, Jung CH.
europepmc   +1 more source

ESI Clinical Practice Guidelines for the Evaluation and Management of Obesity in India - An Update (2025). [PDF]

Indian J Endocrinol Metab
Madhu SV, Kapoor N, Das S, Raizada N, Kalra S.   +4 more
europepmc   +1 more source

Future Directions in the Medical Treatment of Obesity: A Narrative Review. [PDF]

Adv Ther
Bassatne A, Rizo I.
europepmc   +1 more source

Oral Health Implications of GLP-1 Receptor Agonists and Other Incretin-Based Therapies. [PDF]

J Clin Med
Bijoch J.
europepmc   +1 more source